Related resources
Search for item elsewhere
University researcher(s)
Academic department(s)
ATP-sensitive and inwardly rectifying potassium channels in smooth muscle.
Quayle J, Nelson MT, Standen N
Physiological Reviews. 1997;77( 4):1165-232.
Access to files
Full-text and supplementary files are not available from Manchester eScholar. Use our list of Related resources to find this item elsewhere. Alternatively, request a copy from the Library's Document supply service.
Abstract
The properties and roles of ATP-sensitive (KATP) and inwardly rectifying (KIR) potassium channels are reviewed. Potassium channels regulate the membrane potential of smooth muscle, which controls calcium entry through voltage-dependent calcium channels, and thereby contractility through changes in intracellular calcium. The KATP channel is likely to be composed of members of the inward rectifier channel gene family (Kir6) and sulfonylurea receptor proteins. The KIR channels do not appear to be as widely distributed as KATP channels in smooth muscle and may provide a mechanism by which changes in extracellular K+ can alter smooth muscle membrane potential, and thereby arterial diameter. The KATP channels contribute to the resting membrane conductance of some types of smooth muscle and can open under situations of metabolic compromise. The KATP channels are targets of a wide variety of vasodilators and constrictors, which act, respectively, through adenosine 3',5'-cyclic monophosphate/protein kinase A and protein kinase C. The KATP channels are also activated by a number of synthetic vasodilators (e.g., diazoxide and pinacidil) and are inhibited by the oral hypoglycemic sulfonylurea drugs (e.g., glibenclamide). Together, KATP and KIR channels are important regulators of smooth muscle function and represent important therapeutic targets.
Keyword(s)
Animals; Electrophysiology; Membrane Potentials; Patch-Clamp Techniques; Potassium Channels, Inwardly Rectifying; chemistry: Potassium Channels; drug effects: Vasodilation; pharmacology: Nucleoside Diphosphate Sugars; pharmacology: Vasoconstrictor Agents; pharmacology: Vasodilator Agents; physiology: Adenosine Triphosphate; physiology: Muscle, Smooth; physiology: Muscle, Smooth, Vascular; physiology: Potassium; physiology: Protein Kinases; physiopathology: Brain Ischemia; physiopathology: Diabetes Mellitus; physiopathology: Hyperemia; physiopathology: Hypertension; physiopathology: Shock, Septic